You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
珍寶島(603567.SH):獲得 1.1 類中藥創新藥臨牀試驗批准通知書
格隆匯 07-10 16:45

格隆匯7月10日丨珍寶島(603567.SH)公佈,公司收到國家藥品監督管理局核准簽發的《藥物臨牀試驗批准通知書》,清降和胃顆粒處方是北京中醫藥大學東方醫院消化內科主任、首屆岐黃學者李軍祥教授在繼承中國工程院院士董建華“通降論”①的基礎上根據經典名方加減化裁而來的臨牀經驗方。該藥物具有平調寒熱、和胃降逆之功效。適用於非糜爛性胃食管反流病中醫辨證屬寒熱錯雜證,症見燒心泛酸、噯氣倒飽、胃脘疼痛、喜温喜按、口乾口苦、胸骨後灼痛、大便稀溏,舌紅、苔黃膩或薄黃、脈虛弱等。清降和胃顆粒項目是公司自主研發、具有獨立知識產權的中藥1.1類創新藥,其藥品分類為消化系統類藥物。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account